Zimmer Biomet Holdings Inc (ZBH) Stake Raised by National Pension Service

National Pension Service lifted its holdings in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 6.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 198,495 shares of the medical equipment provider’s stock after buying an additional 11,695 shares during the period. National Pension Service owned 0.10% of Zimmer Biomet worth $23,952,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the stock. Advisory Services Network LLC grew its position in shares of Zimmer Biomet by 1.0% during the 2nd quarter. Advisory Services Network LLC now owns 3,690 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 37 shares during the last quarter. D.A. Davidson & CO. grew its position in shares of Zimmer Biomet by 0.9% during the 2nd quarter. D.A. Davidson & CO. now owns 16,321 shares of the medical equipment provider’s stock valued at $2,095,000 after buying an additional 140 shares during the last quarter. Gofen & Glossberg LLC IL grew its position in shares of Zimmer Biomet by 2.7% during the 2nd quarter. Gofen & Glossberg LLC IL now owns 6,060 shares of the medical equipment provider’s stock valued at $778,000 after buying an additional 161 shares during the last quarter. Peapack Gladstone Financial Corp grew its position in Zimmer Biomet by 4.5% in the 2nd quarter. Peapack Gladstone Financial Corp now owns 5,125 shares of the medical equipment provider’s stock worth $658,000 after purchasing an additional 221 shares during the last quarter. Finally, Greenwood Gearhart Inc. grew its position in Zimmer Biomet by 0.6% in the 2nd quarter. Greenwood Gearhart Inc. now owns 39,569 shares of the medical equipment provider’s stock worth $5,081,000 after purchasing an additional 240 shares during the last quarter. 86.18% of the stock is owned by institutional investors and hedge funds.

Several research analysts have commented on the stock. Goldman Sachs Group upgraded shares of Zimmer Biomet from a “sell” rating to a “neutral” rating and set a $125.00 target price for the company in a research report on Tuesday, December 19th. Stifel Nicolaus upgraded shares of Zimmer Biomet from a “hold” rating to a “buy” rating and upped their target price for the stock from $120.00 to $168.00 in a research report on Wednesday, January 31st. Canaccord Genuity restated a “hold” rating and issued a $132.00 target price on shares of Zimmer Biomet in a research report on Friday, January 5th. Robert W. Baird restated a “buy” rating on shares of Zimmer Biomet in a research report on Wednesday, January 31st. Finally, BMO Capital Markets restated a “buy” rating and issued a $142.00 target price on shares of Zimmer Biomet in a research report on Tuesday, December 12th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. Zimmer Biomet currently has an average rating of “Buy” and a consensus target price of $141.67.

Shares of Zimmer Biomet Holdings Inc (NYSE ZBH) traded up $0.86 during trading hours on Friday, hitting $116.39. 2,142,699 shares of the stock were exchanged, compared to its average volume of 1,505,606. The firm has a market cap of $23,565.83, a price-to-earnings ratio of 12.92, a P/E/G ratio of 2.04 and a beta of 1.08. Zimmer Biomet Holdings Inc has a 12 month low of $108.03 and a 12 month high of $133.49. The company has a current ratio of 1.52, a quick ratio of 0.83 and a debt-to-equity ratio of 0.76.

Zimmer Biomet (NYSE:ZBH) last released its earnings results on Tuesday, January 30th. The medical equipment provider reported $2.10 EPS for the quarter, meeting the consensus estimate of $2.10. Zimmer Biomet had a net margin of 23.51% and a return on equity of 15.45%. The business had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same period in the prior year, the business earned $2.14 earnings per share. The business’s quarterly revenue was up 3.0% on a year-over-year basis. equities analysts forecast that Zimmer Biomet Holdings Inc will post 7.82 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, January 29th. Investors of record on Friday, December 29th were paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.82%. The ex-dividend date was Thursday, December 28th. Zimmer Biomet’s dividend payout ratio is presently 10.65%.

ILLEGAL ACTIVITY WARNING: This article was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://stocknewstimes.com/2018/02/11/zimmer-biomet-holdings-inc-zbh-position-raised-by-national-pension-service.html.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply